Search research articles
Contact Us
Filters
Showing results (91-100 of 135) with videos related to
Page
of 14
Sort By:
Blood Advances
|
September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
Urvi A Shah, Erin Moshier, Andriy Derkach, et al.
Ebiomedicine
|
December 24, 2018
Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies
Andriy Derkach, Isaac Otim, Ruth M Pfeiffer, et al.
Leukemia & Lymphoma
|
October 25, 2022
A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
Karthik Nath, Tala Shekarkhand, Meghan Salcedo, et al.
Research Square
|
February 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma
Alexander Lesokhin, Karthik Nath, Tala Shekarkhand, et al.
Blood Neoplasia
|
June 27, 2025
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience
Malin Hultcrantz, Andriy Derkach, Hani Hassoun, et al.
Blood Cancer Journal
|
November 2, 2025
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
Eric Jurgens, Tala Shekarkhand, Colin Rueda, et al.
Blood Cancer Journal
|
April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma
Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Eclinicalmedicine
|
March 10, 2023
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study
Neha Korde, Elizabet Tavitian, Donna Mastey, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Blood Cancer Journal
|
April 21, 2022
Nutrition perceptions, needs and practices among patients with plasma cell disorders
Maria A Malik, Nathan W Sweeney, Mohammad Jafri, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 135) with videos related to
Sort By:
Page
of 14
Blood Advances
|
September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
Urvi A Shah, Erin Moshier, Andriy Derkach, et al.
Ebiomedicine
|
December 24, 2018
Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies
Andriy Derkach, Isaac Otim, Ruth M Pfeiffer, et al.
Leukemia & Lymphoma
|
October 25, 2022
A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
Karthik Nath, Tala Shekarkhand, Meghan Salcedo, et al.
Research Square
|
February 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma
Alexander Lesokhin, Karthik Nath, Tala Shekarkhand, et al.
Blood Neoplasia
|
June 27, 2025
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience
Malin Hultcrantz, Andriy Derkach, Hani Hassoun, et al.
Blood Cancer Journal
|
November 2, 2025
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
Eric Jurgens, Tala Shekarkhand, Colin Rueda, et al.
Blood Cancer Journal
|
April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma
Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Eclinicalmedicine
|
March 10, 2023
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study
Neha Korde, Elizabet Tavitian, Donna Mastey, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Blood Cancer Journal
|
April 21, 2022
Nutrition perceptions, needs and practices among patients with plasma cell disorders
Maria A Malik, Nathan W Sweeney, Mohammad Jafri, et al.
Page
of 14